Multidisciplinary Design Opimization (MDO)
Award amount
$548,902Program and phase
SBIR · Phase IIAward year
1996Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- TARGAZYME, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NJG4X7NZ4BM1
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVHD
- Novel cell-based Restorative Approach in Treatment of Diabetes-related Retinopath
- Therapeutic Potential and Targeted Homing of ECSOD-MSCs in Animal Model of Mucositi
- Increased Therapeutic Potential of Migrating Neural Stem Cells and ASC101 Treatment
- ASC101 Enhancement of Regenerative Capacity of Amniotic Fluid-derived Stem Cells
Research funding history
27 SBIR/STTR records share this UEI (1983–2015). Reported award amounts total $7,779,967. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Commerce